Study to Examine Multiple Doses of TMC647055 in Combination With Telaprevir
Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess safety, tolerability, pharmacokinetics (how the drug
is absorbed into the bloodstream) and antiviral activity of repeated doses of TMC647055 given
in combination with telaprevir in HCV infected patients. TMC647055 is being investigated for
the treatment of hepatitis C infection. Telaprevir has recently been approved in the USA and
in Europe for the treatment of chronic hepatitis C infected patients.